Despite extraordinary advances in potent antiretroviral therapies that are capable of altering the course of the disease for many patients, HIV research continues to present new challenges whose study and resolution require innovative new statistical methodology for design and analysis of HIV clinical trials. In the extension period of this MERIT award, new statistical methods will be developed that offer cutting-edge solutions to fundamental and emerging challenges in HIV clinical research that may be translated into accessible tools for data analysts. Lifelong commitment to antiretroviral therapy is complicated by side-effects, toxicities, drug resistance, costs, and life style factors, and developing strategies for use of these therapies over time that can circumvent these issues and still sustain viral suppression and preserve immunological function are a central focus of HIV research. In the first project, a realistic, principled framework for trial design and analysis in which such time-dependent HIV treatment strategies may be conceived and evaluated feasibly will be developed. Clinical trials focusing on the difference in two treatments are a mainstay of HIV research, but the analysis of such trials is often complicated by missing data and uncertainty over whether and how to incorporate additional auxiliary information on the subjects. In the second project, a unified statistical framework to address these issues that will lead to accessible techniques for practitioners will be developed. Characterizing the relationship between longitudinal measures of biomarkers (e.g., CD4, viral load) and long-term clinical endpoints such as disease progression is of widespread interest in HIV research;e.g., models for this purpose are an important tool in the evaluation of biomarkers as potential surrogate endpoints. In the third project, a new, computationally feasible approach that leads to efficient inferences will be formulated. Relevance: This project will provide HIV researchers with new tools to conceive and evaluate new treatment strategies for HIV infection, including strategies for how best to treat HIV-infected individuals over time while avoiding problems of drug resistance and side effects. New methods for data analysis to help researchers understand the relationships between markers such as CD4 and disease progression will also be developed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI031789-21
Application #
8013617
Study Section
Special Emphasis Panel (NSS)
Program Officer
Gezmu, Misrak
Project Start
1991-07-01
Project End
2013-02-28
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
21
Fiscal Year
2011
Total Cost
$359,001
Indirect Cost
Name
North Carolina State University Raleigh
Department
Biostatistics & Other Math Sci
Type
Schools of Arts and Sciences
DUNS #
042092122
City
Raleigh
State
NC
Country
United States
Zip Code
27695
Milanzi, Elasma; Molenberghs, Geert; Alonso, Ariel et al. (2016) Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules. J Biom Biostat 7:
Milanzi, Elasma; Molenberghs, Geert; Alonso, Ariel et al. (2015) Estimation After a Group Sequential Trial. Stat Biosci 7:187-205
Bernhardt, Paul W; Zhang, Daowen; Wang, Huixia Judy (2015) A Fast EM Algorithm for Fitting Joint Models of a Binary Response and Multiple Longitudinal Covariates Subject to Detection Limits. Comput Stat Data Anal 85:37-53
Vock, David M; Davidian, Marie; Tsiatis, Anastasios A (2014) SNP_NLMM: A SAS Macro to Implement a Flexible Random Effects Density for Generalized Linear and Nonlinear Mixed Models. J Stat Softw 56:2
Verbeke, Geert; Fieuws, Steffen; Molenberghs, Geert et al. (2014) The analysis of multivariate longitudinal data: a review. Stat Methods Med Res 23:42-59
Schulte, Phillip J; Tsiatis, Anastasios A; Laber, Eric B et al. (2014) Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes. Stat Sci 29:640-661
Molenberghs, Geert; Kenward, Michael G; Aerts, Marc et al. (2014) On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data. Stat Methods Med Res 23:11-41
Bai, Xiaofei; Tsiatis, Anastasios A; O'Brien, Sean M (2013) Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. Biometrics 69:830-9
Zhang, Baqun; Tsiatis, Anastasios A; Laber, Eric B et al. (2013) Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions. Biometrika 100:
Vock, David M; Tsiatis, Anastasios A; Davidian, Marie et al. (2013) Assessing the causal effect of organ transplantation on the distribution of residual lifetime. Biometrics 69:820-9

Showing the most recent 10 out of 51 publications